Moderna, Inc. vs NextEra Energy, Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while NextEra Energy, Inc. trades at $87.97 (market cap $183.53B). The key difference: NextEra Energy, Inc. is far larger — about 7.8× Moderna, Inc.'s market cap, and NextEra Energy, Inc. pays a 2.83% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| MRNA | NEE | |
|---|---|---|
Market Cap | $23.60B | $183.53B |
Sector | Health | Utilities |
52-Week High | $81.80 | $97.88 |
52-Week Low | $22.36 | $69.77 |
Enterprise Value | $19.70B | $285.94B |
Dividend Yield | — | 2.83% |
Trailing returns across standard periods
Latest headlines on both assets
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →NextEra Energy's regulated utility, Florida Power & Light, distributes power to more than 5 million customers in Florida. FP&L contributes more than 60% of the group's operating earnings. The renewable energy segment generates and sells power throughout the United States and Canada. Consolidated generation capacity totals more than 50 gigawatts and includes natural gas, nuclear, wind, and solar assets.
Read more on NEE →